Results: HFHS diet led to vacuolization and thyroidisation of the renal tubules. Glucose caused mitochondrial fragmentation and cellular apoptosis in HK2 cells. Autophagy was activated in glucose-treated cells as evidenced by the enhanced LC3B-II expression and autophagosome formation. When autophagy was inhibited, either by the inhibitor, 3-MA, or by siATG5, tubular cells were more susceptible to glucose-induced mitochondrial fragmentation and cellular apoptosis. When MFN1 or MFN2 was knockdown, mitochondria became more fragmented and autophagy was activated. When FIS1 was silenced, mitochondria were not fragmented and the expressions of LC3B-II, p62 and BECN1 remained unchanged. Conclusion: Our results characterized the pathology of diabetic tubulopathy and suggested that glucose leads to mitochondrial fragmentation and cellular apoptosis in renal tubules. We also offered evidence that autophagy protects mitochondrial from fragmentation in renal tubules. Objective: Tangshen Formula (TSF), a traditional Chinese medicine, had been reported to have beneficial effects on diabetic nephropathy (DN), but its action mechanism is still unclear. The study was designed to elucidate the potential mechanism of TSF in treating DN. Methods: Type 2 DN rat models were established by high-fat diet-fed and low-dose-streptozotocin injection. The rats were treated with or without TSF by gavage for 20 weeks and examined by 24h-albuminuria, histology, immunohistochemistry, molecular analyses.
Objective: In diabetic nephropathy, it has been proven lipotoxicity is an important pathological mechanism of progressive tubulointerstitial injury. Electron transport flavoprotein (ETF) is an electron acceptor in fatty acid b oxidation, which is composed by a and b subunits. Our previous studies have found ETFb point mutations in conserved sequences by renal cortex proteome in diabetic nephropathy. In this study, the expression and distribution of ETFb and its role in diabetic kidney damage were explored to provide new ideas for further insight into the pathogenesis of diabetic nephropathy. 
times).
Results: The average estimated glomerular filtration rate was 24.5 (12.0e40.0) ml/min/1.73 m 2 and the average urine protein-to-creatinine ratio (UPCR) was 1448 (471e3622) mg/g. Among 102 patients received biopsy, 42 patients (41.2%) had biopsy-proven diabetic nephropathy. We observed that haematuria was associated with age, UPCR, duration of diabetes, mean blood pressure, albumin, glycated haemoglobin, and C-reactive protein. The hazard ratio (HR) of moderate haematuria for ESRD was 1.39 (95% confidence interval [CI]: 1.10e1.76, P < 0.001). The odds ratios (ORs) of moderate haematuria for rapid renal progression wad 1.81 (95% CI: 1.29e2.53, P < 0.001). Moreover, the HRs of mild haematuria and moderate haematuria for mortality were 1.43 (95% CI: 1.12e1.84, P Z 0.005) and 1.73 (95% CI: 1.27e2.36, P < 0.001), respectively. In the subgroup analysis, we observed that the association between haematuria and ESRD was more prominent in patients with CKD stages 1e3 or UPCR <500 mg/g. Conclusion: Microscopic haematuria in patients with diabetic CKD is associated with risks for ESRD and mortality. 
S6 Diabetic Nephropathy
Methods: Bring into the DKD patients through pathological diagnosis which have more than one year disease course, to classify by the Objective: Diabetic nephropathy (DN) is one of the most severe microvascular complications of diabetes. Recently, Berberine (BBR) has the beneficial effects to diabetes. The aim of this study is to observe the renoprotective effect and mechanisms of berberine in a type 2 diabetes nephropathy on rat. Methods: Twenty seven male Wistar rats (8-wk old, 200e250 g) randomly divided into 9 rats in normal control and 18 rats in diabetic groups. Diabetic rats were fed with a high-fat diet (consisting of 50% carbohydrate, 12% protein, and 38% fat) for 5 wk, followed by intraperitoneal injection with a single lowdose of streptozotocin (STZ, 25 mg/kg) after 12-h fasting. The normal control rats were fed with a standard chow diet. Diabetic rats were randomly divided into two subgroups: vehicle treated and BBR treated (n Z 9 each). Rats were housed individually in metabolic cages for 24-h urinary collection at 4-wk intervals. Rats were sacrificed 20 weeks later. We detected the kidney weight index, 24 h urine protein, morphology study, inflammation and fibrosis markers, such as IkBa, TGFb1, TbRI and Smad7 by realtime-PCR and Western Blot.
Results: (1) Compared with normal rats, the diabetic rats showed higher kidney weight index and 24h urine protein, berberine treatment decreased kidney weight index and 24 h urine protein. (2) Objectives: Tangshen Formula (TSF) is a Chinese herbal medicine used for DN treatment. In the current study, we aimed to identify the core regulatory region of QDPR gene promoter. We also studied whether the Tangshen Formula could up-regulate QDPR promoter activity in vitro study and to investigate the Tangshen Formula's mechanism at molecular level.
Results: Identification of core regulatory region in QDPR gene promoter: as compared with À2092 w À1 fragment, the relative fluorescence intensity of the deleted fragment À529 w À116 reduced to 1% (P < 0.01), the fragment which contained À529 w À1 kept 64% (P < 0.05). The relative fluorescence intensity of those deleted fragments À529 w À429, À428 w À250 and À141 w À116 were increased (P < 0.01), and the deleted fragment À249 w À142 was decreased (P < 0.05). QDPR gene promoter could be recognized as Tangshen Formula's drug targets: LDH experimental data showed that: the suitable Tangshen Formula's concentration in cell experiment were 800 g/ml or less. Results showed that: Tangshen Formula can improve QDPR gene promoter activity. Tangshen Formula can improve D5'/pGL3, D3/pGL3, D4/pGL3 three recombinant plasmids activity. But comparing with no drug treated group, drug treated group is no effect on D1-4/pGL3, D1/pGL3, D2/pGL3's activity (P > 0.01). Conclusion: Rat QDPR core regulatory region might locate between À529 and À116 where existing putative negative and positive regulatory elements, especially, existing several Sp1 binding sites. There may be a potential Sp1 binding sites at À141w À116 which could inhibit the transcriptional activity of the promoter.
